(Q42205079)

18 October 2017

Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load (English)

1 reference

18 October 2017

1 reference

1 reference

1 reference

16

Geneviève Chêne

1 reference

18 October 2017

17

Jacques Banchereau

1 reference

18 October 2017

Carson Harrod

8

0 references

Christine Lacabaratz

object named as

Christine Lacabaratz

4

0 references

Rodolphe Thiébaut

2

object named as

Rodolphe Thiébaut

1 reference

18 October 2017

14

Constance Delaugerre

1 reference

18 October 2017

18

Karolina Palucka

1 reference

18 October 2017

Yves Lévy

1

1 reference

18 October 2017

Monica Montes

3

1 reference

18 October 2017

Louis Sloan

5

1 reference

18 October 2017

Bryan King

6

1 reference

18 October 2017

Sophie Pérusat

7

1 reference

18 October 2017

Amanda Cobb

9

1 reference

18 October 2017

Lee K Roberts

10

1 reference

18 October 2017

Mathieu Surenaud

11

1 reference

18 October 2017

Céline Boucherie

12

1 reference

18 October 2017

Sandra Zurawski

13

1 reference

18 October 2017

Laura Richert

15

1 reference

18 October 2017

language of work or name

English

0 references

publication date

1 September 2014

1 reference

European Journal of Immunology

18 October 2017

1 reference

18 October 2017

44

1 reference

18 October 2017

9

1 reference

18 October 2017

2802-2810

1 reference

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

18 October 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

Preparation for antiretroviral interruption by boosting the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

Therapeutic dendritic-cell vaccine for chronic HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

Development of a HIV-1 lipopeptide antigen pulsed therapeutic dendritic cell vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

Interleukin-21-producing HIV-1-specific CD8 T cells are preferentially seen in elite controllers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

IL-21R on T cells is critical for sustained functionality and control of chronic viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

Regulating the immune response to tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

Combining several ordinal measures in clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344433

21 January 2018

Identifiers

DOI

10.1002/EJI.201344433

1 reference

18 October 2017

1 reference